Skip to main content
OpenTrials

Clinical trial condition

Giant Cell Arteritis

Explore clinical trials studying Giant Cell Arteritis. Study availability and eligibility vary by location and protocol.

113 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Giant Cell Arteritis trial results

Completed

Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA)

NCT04930094

Conditions
Arteritis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +14 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • IRIS Research and Development Plantation, Florida, United States
  • Sarasota Arthritis Res Ctr Sarasota, Florida, United States
  • Novartis Investigative Site Iowa City, Iowa, United States
View all 104 locations
View Trial Details
Completed

Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission

NCT05380453

Conditions
Arteritis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +18 more
Locations
  • Novartis Investigative Site Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Würzburg, Bavaria, Germany
  • Novartis Investigative Site Göttingen, Lower Saxony, Germany
  • Novartis Investigative Site Düsseldorf, North Rhine-Westphalia, Germany
View all 25 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis

NCT03725202

Conditions
Arteritis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +14 more
Locations
  • Rheum Assoc of North Alabama /ID# 168668 Huntsville, Alabama, United States
  • Arizona Arthritis and Rheumatology Research - Glendale Office /ID# 204702 Glendale, Arizona, United States
  • VA Long Beach Healthcare System /ID# 203833 Long Beach, California, United States
  • Robin K. Dore MD, Inc /ID# 201950 Tustin, California, United States
View all 172 locations
View Trial Details
Completed

Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis

NCT03482479

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Aortic Arch Syndromes, Aortic Diseases, +33 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

FDG Digital PET/CT as First Line Investigation for Giant Cell Arteritis

NCT05000138

Conditions
Arteritis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +13 more
Locations
  • Hôpital du Sacré-Cœur de Montréal Montreal, Quebec, Canada
  • Jewish General Hospital Montreal, Quebec, Canada
  • CHUS Sherbrooke, Quebec, Canada
  • Université Bourgogne Europe, Centre Georges-François Leclerc Dijon, France
View Trial Details

Related conditions